MedPath

How Effective is Nebulization With 3% Hypertonic Saline Against 0.9% Normal Saline In Children With Viral Lung Infection.

Phase 2
Conditions
Health Condition 1: J219- Acute bronchiolitis, unspecified
Registration Number
CTRI/2024/02/063234
Lead Sponsor
E AJAYA KUMAR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Previously healthy infants and children below 24 months of age admitted with first episode of respiratory tract infection with wheeze, starting as a viral upper respiratory infection (coryza, cough, fever), and a clinical severity score above 04.

Exclusion Criteria

Children with previous episode of wheezing, chronic cardio-pulmonary disease or immunodeficiency; critical illness at presentation requiring ventilator support; the use of nebulised HS within the previous 12 hours; or premature birth (gestational age 34 weeks), X Ray showing significant findings like consolidation patches, collapse lung, pleural effusion will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath